free web stats

Law Offices of Thomas J. Lamb

Zantac Recall: Chemical NDMA In Zantac Pills Can Cause Cancers

By

The contaminant chemical NDMA in Zantac pills is a substance that could cause cancer of the: pancreas (pancreatic cancer), stomach, colon, rectum (rectal cancer), bladder, or kidney (renal cancer). On April 1, 2020, the FDA announced that it was requesting a Zantac recall due to the presence of NDMA in Zantac and all other medications containing ranitidine.

Even before this Zantac recall, our law firm is currently investigating possible Zantac cancer lawsuits for personal injury and wrongful death cases. Please feel free to contact us if you want help evaluating a Zantac case. This service is free, confidential, and there is no obligation.

For background, we suggest you may want to read this November 29, 2019 article, “Zantac FDA Warning In September 2019 Leads To Lawsuits For Patients Diagnosed With Cancer“, posted on our Drug Injury Watch blog.

For details about this Zantac recall and the chemical NDMA in Zantac pills you can look at this document, “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market”, issued by the FDA on April 1, 2020.

[Read article in full at original source]

Zantac

Free Case Evaluation

Strictly Confidential, No Obligation

Ranitidine In Zantac Might Produce NDMA As A Result Of Heat Effect

By

There is a new Zantac-NDMA mechanism of action theory which suggests that when ranitidine is exposed to heat it produces unsafe levels of NDMA (nitrosamine impurity called N-nitrosodimethylamine), a probable human carcinogen.  Ranitidine is the active ingredient in Zantac.

From this January 2, 2020, Bloomberg news report about this Zantac-NDMA mechanism of action, “Carcinogen in Heartburn Drug May Build in Storage, Lab Finds”, we are presented with this possible scenario:

The heartburn medicine Zantac appears to produce unacceptably high levels of a cancer-causing chemical when exposed to heat for as little as five days, according to a testing laboratory….

New testing by an Alameda, California-based independent laboratory called Emery Pharma found that a combination of heat and time can raise levels of NDMA, potentially while drugs are sitting in packaging well after being analyzed by their manufacturers….

“The more you heat it, the more NDMA you generate,” Emery CEO Ron Najafi said in a telephone interview. “I am worried that if it just sits at home at room temperature, it could gradually generate NDMA.”

Our law firm is currently investigating possible Zantac cancer lawsuits for personal injury and wrongful death cases.

[Read article in full at original source]

Zantac

Free Case Evaluation

Strictly Confidential, No Obligation

Zantac Cancer Lawsuits Filed After FDA Warnings About NDMA In Ranitidine

By

Zantac cancer lawsuits are for being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach.

According to medical research, some of the cancers associated with Zantac use due to NDMA exposure include:

    • Stomach cancer
    • Colon cancer
    • Rectal cancer
    • Bladder cancer
    • Kidney cancer
    • Pancreatic cancer

This situation is due to the fact that Zantac contains NDMA (nitrosamine impurity called N-nitrosodimethylamine), a probable human carcinogen. according to a September 13, 2019 FDA Press Announcement, “Statement alerting patients and health care professionals of NDMA found in samples of ranitidine”.

Ranitidine is the active ingredient in Zantac — both brand name prescription Zantac as well as over the counter, or OTC, Zantac which can be bought without a doctor’s prescription at any pharmacy.

Our law firm is currently investigating possible Zantac cancer lawsuits for personal injury and wrongful death cases. Please feel free to contact us if you want help evaluating a Zantac case. This service is free, confidential, and there is no obligation.

[Read article in full at original source]

Zantac

Free Case Evaluation

Strictly Confidential, No Obligation

Our Other Websites

Drug Injury Watch

Drug Safety Developments

Lamb Law Office

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com